Fructosamine

Revision as of 21:03, 7 February 2013 by Vishnu Vardhan Serla (talk | contribs) (→‎Footnotes)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Diabetes

WikiDoc Resources for Fructosamine

Articles

Most recent articles on Fructosamine

Most cited articles on Fructosamine

Review articles on Fructosamine

Articles on Fructosamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fructosamine

Images of Fructosamine

Photos of Fructosamine

Podcasts & MP3s on Fructosamine

Videos on Fructosamine

Evidence Based Medicine

Cochrane Collaboration on Fructosamine

Bandolier on Fructosamine

TRIP on Fructosamine

Clinical Trials

Ongoing Trials on Fructosamine at Clinical Trials.gov

Trial results on Fructosamine

Clinical Trials on Fructosamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fructosamine

NICE Guidance on Fructosamine

NHS PRODIGY Guidance

FDA on Fructosamine

CDC on Fructosamine

Books

Books on Fructosamine

News

Fructosamine in the news

Be alerted to news on Fructosamine

News trends on Fructosamine

Commentary

Blogs on Fructosamine

Definitions

Definitions of Fructosamine

Patient Resources / Community

Patient resources on Fructosamine

Discussion groups on Fructosamine

Patient Handouts on Fructosamine

Directions to Hospitals Treating Fructosamine

Risk calculators and risk factors for Fructosamine

Healthcare Provider Resources

Symptoms of Fructosamine

Causes & Risk Factors for Fructosamine

Diagnostic studies for Fructosamine

Treatment of Fructosamine

Continuing Medical Education (CME)

CME Programs on Fructosamine

International

Fructosamine en Espanol

Fructosamine en Francais

Business

Fructosamine in the Marketplace

Patents on Fructosamine

Experimental / Informatics

List of terms related to Fructosamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Fructosamine is a compound which can be considered as the result of a reaction between fructose and ammonia or an amine (with a molecule of water being released). A fructosamine is also formed when carbonyl group of glucose reacts with an amino group of a protein, as the double bond to oxygen moves from the end carbon atom to the next carbon atom and water is released. Fructosamines formed from blood proteins such as serum albumin are known as Glycated Serum Protein (GSP) or Glycated Albumin, and are used to identify the plasma glucose concentration over time and so assess diabetic control.[1]

Indications

More commonly diabetics have their glucose control assessed with the Glycosylated hemoglobin measurement that assesses average glucose levels over the preceding 6 weeks; as reflected by the permanent glycosylation of a small fraction of the hemoglobin molecules in their blood. However, this is not appropriate where there has been a recent change in diet or treatment within 6 weeks, nor if there are abnormalities of red blood cell aging process or mix of hemoglobin subtypes (predominantly HbA in normal adults). Hence people with recent blood loss or hemolytic anemia, or hemoglobinopathy such as sickle-cell disease are not suitable for some glycosylated hemoglobin methods that do not account for higher-turnover hemoglobin. Fructosamine is used in these circumstances, as it also reflects an average of blood glucose levels, but over a shorter period of 2 to 3 weeks. Fructosamine is also of use in conditions, such as pregnancy, in which hormonal changes cause greater short-term fluctuation in glucose concentrations.

Interpretation of Results

There is no standard reference range available for this test. The reference values depends upon the factors of patient age, gender, sample population and test method. Hence each laboratory reports will include their specific reference range for the test.

An increase in fructosamine in lab testing results usually means an increase in glucose in the blood.

Approximately each change of 3.3 mmol (60 mg/dl) in average blood sugar levels will give rise to changes of 2% HbA1c and 75 µmol fructosamine values.[2]

Related Chapters

References

  1. Delpierre G, Collard F, Fortpied J and Van Sschaftingen E (2002). "Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes" (PDF). Biochem. J. 365: 801–8.
  2. Bartol T (December 1, 2000). "Comparison of Blood Glucose, HbA1c, and Fructosamine". Retrieved 2007-06-04. - gives a comparison chart and cites following source:
    • Nathan DM, Singer DE, Hurxthal K, Goodson JD (1984). "The clinical information value of the glycosylated hemoglobin assay". N. Engl. J. Med. 310 (6): 341–6. PMID 6690962.

de:Fructosamin


Template:WikiDoc Sources